Midodrine Use in Septic Shock

Midodrine Use in Septic Shock

The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.

Pharmaceutical medication involved
Patients and healthy individuals accepted

Drug - Midodrine Hydrochloride

Midodrine Hydrochloride, enteral, 10 or 20 mg


investigational pharmacy formulated placebo comparator

Midodrine Use for Hypotension Requiring IV Vasopressor Therapy in Early Septic Shock